TAG, CRAG, and other civil society organizations sent this letter to The Union, asking them, as producers of the world’s largest TB conference and publisher of the field’s flagship journal to lead by example...
150 organizations called on six pharmaceutical companies to continue funding the vital D:A:D study. 150 HIV Organizations Urge Continuation of D:A:D Study
We write as professionals, activists, and public health researchers who have worked to combat AIDS and other infectious diseases in the United States and around the world for over three decades.
Letter from TAG and others asking for withdrawal of mandatory quarantine requirement for entering the US through Newark and JFK airports who have had direct contact with individuals with Ebola Virus Disease in Guinea, Liberia, and Sierra Leone.
Letter from TAG and other advocates expressing concerns about proposed Medicaid criteria that will limit access to sofosbuvir and other lifesaving hepatitis C medications.
Letter asking to speak to key staff at Novartis to discuss its support of the clinical research required to more fully understand the efficacy of Menveo in adolescents and adults living with HIV.
Follow-up to January 14, 2014 letter regarding the development of a plan to end AIDS in New York State.
February 13, 2014 TAG, CRAG, and the TB CAB sent an open letter to AstraZeneca urging their continued investment in tuberculosis research despite the cessation of AstraZeneca’s Neglected Tropical Diseases, Tuberculosis, and Malaria Program. Read/Download the TAG, CRAG, TB CAB…
This letter from CRAG (TB Community Research Advisors Group) and TAG was sent to Anne Whitaker, President, North America Pharmaceuticals of Sanofi US. It commends Sanofi for making this commitment to lower the price of rifapentine for Public Health Service…
TAG, CRAG, and the TB CAB issues urgent appeal for Otsuka to initiate its long overdue compassionate use program by the end of 2013.